Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

26.5K
Metabolic memory is the phenomenon by which diabetic complications persist and progress unimpeded even after euglycemia is achieved pharmaceutically. Here we describe a diabetes mellitus zebrafish model which is unique in that it allows for the examination of the mitotically transmissible epigenetic components of metabolic memory in...
26.5K
Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus04:26

Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus

3.1K
This video describes the technique of creating a zebrafish model for Type 1 diabetes mellitus with the help of the drug Streptozocin, to study the pathophysiology of diabetic complications and metabolic...
3.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

6.2K
6.2K
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice11:57

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

10.7K
This protocol demonstrates murine islet isolation and seeding onto a decellularized scaffold. Scaffold-supported islets were transplanted into the epididymal fat pad of streptozotocin (STZ)-induced diabetic mice. Islets survived at the transplantation site and reversed the hyperglycemic...
10.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of glucagon-like peptide-1 receptor analogues in kidney transplant recipients with diabetes: A single-centre retrospective study.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Addressing inequalities in access and care in type 1 diabetes - The North-East London Type 1 Diabetes Transformation (NATALIE) project.

Primary care diabetes·2026
Same author

Diabetes: A multisystem disease needing multidisciplinary care.

Clinical medicine (London, England)·2026
Same author

Using automated insulin delivery to address the clinical challenges of glycemic management in people with type 1 diabetes and kidney failure on maintenance hemodialysis.

Journal of diabetes investigation·2025
Same author

Association of British Clinical Diabetologists and UK Kidney Association Joint Clinical Practice Guidelines for the Pharmacological Management of Hyperglycemia in Adults With Type 2 Diabetes Mellitus and CKD.

Kidney international reports·2025
Same author

Diabetes and transplantation.

Clinical medicine (London, England)·2025

Related Experiment Video

Updated: Jan 19, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.5K

Post-transplant diabetes mellitus.

Tahseen A Chowdhury1

  • 1The Royal London Hospital, London, UK tahseen.chowdhury@nhs.net.

Clinical Medicine (London, England)
|September 19, 2019
PubMed
Summary

Post-transplant diabetes mellitus (PTDM) is a common complication after organ transplants, increasing risks for graft failure and mortality. Early screening and active management, including lifestyle advice and medication, are crucial for transplant recipients.

Area of Science:

  • Nephrology
  • Endocrinology
  • Immunology

Background:

  • Post-transplant diabetes mellitus (PTDM) is a frequent complication after solid organ transplantation.
  • PTDM is associated with increased risks of graft failure and patient mortality.
  • Risk factors include standard diabetes predictors, immunosuppressive medications, and infections like hepatitis C.

Purpose of the Study:

  • To highlight the prevalence and risks associated with PTDM.
  • To outline screening and management strategies for PTDM in transplant recipients.

Main Methods:

  • Screening for diabetes during transplant assessment.
  • Managing early post-operative hyperglycemia with insulin.
  • Considering oral hypoglycemic agents upon clinical stability.
Keywords:
Post-transplant diabetesimmunosuppressiontransplantation

More Related Videos

Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus
04:26

Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus

Published on: April 30, 2023

3.1K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K

Related Experiment Videos

Last Updated: Jan 19, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.5K
Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus
04:26

Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus

Published on: April 30, 2023

3.1K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K
  • Active screening and management of PTDM in all transplant recipients.

    • Main Results:

    • PTDM is a significant risk factor for adverse outcomes in transplant patients.
    • Early hyperglycemia is best managed with insulin.
    • Lifestyle advice can mitigate PTDM risk in high-risk individuals.

    Conclusions:

    • Active screening for PTDM is recommended for all transplant recipients.
    • Comprehensive management including education, complication screening, cardiovascular risk reduction, and anti-hyperglycemic therapy is essential.
    • Despite limited randomized trial data, proactive PTDM management is vital.